Sun Jian, Wen Qing-Hui, Li Xia, Song Yu, Jin Jin, Ma Ji-Sheng, Zhou Qiu-Li
School of Pharmacy, Jilin University, Changchun 130021, China.
Zhongguo Zhong Yao Za Zhi. 2006 Sep;31(18):1526-9.
To make a comparison between the antitumor effect and the chemical constituents of Huanglian Jiedu decoction (HLJDT) and that of serum containing HLJDT.
Based on the established chromatographic fingerprint of HLJDT, analysis and comparison were made between the HPLC fingerprints of rat serum samples obtained after orally taking HLJDT and those of control rat serum samples. The different effects on NCI-H446 and Bel-74024 cancer cells from human were investigated in vitro using HLJDT and its serum. The inhibitory effects of HLJDT and its serum were observed by MTT assay.
Ten compounds of HLJDT and some metabolites were detected after oral administration of HLJDT, and however some main compounds of HLJDT were not detected in serum. Both HLJDT and its serum in different dosage groups could inhibit the proliferation of NCI-H446 and Bel-7402 cancer cells from human in a dose-dependent manner, but inhibitory grade was different in the two cancer cell lines. HLJDT had more inhibitory effect on Bel-7402 than on NCI-H446, on the other hand serum containing HLJDT had the same inhibitory effect on Bel-7402 and NCI-H446.
The reason for inhibitory grade change was that the proportion of concentration of many compounds in serum containing HLJDT was different to that in HLJDT, which should be subject to thorough investigation so as to illuminate the pharmacology and active mechanism of HLJDT.
比较黄连解毒汤(HLJDT)及其含药血清的抗肿瘤作用和化学成分。
基于已建立的HLJDT色谱指纹图谱,对口服HLJDT后大鼠血清样品与对照大鼠血清样品的HPLC指纹图谱进行分析比较。体外研究HLJDT及其含药血清对人NCI-H446和Bel-74024癌细胞的不同作用。采用MTT法观察HLJDT及其含药血清的抑制作用。
口服HLJDT后检测到HLJDT的10种化合物及一些代谢产物,但血清中未检测到HLJDT的一些主要化合物。不同剂量组的HLJDT及其含药血清均能剂量依赖性抑制人NCI-H446和Bel-7402癌细胞的增殖,但对两种癌细胞系的抑制程度不同。HLJDT对Bel-7402的抑制作用比对NCI-H446的抑制作用更强,而含药血清对Bel-7402和NCI-H446的抑制作用相同。
抑制程度变化的原因是含药血清中多种化合物的浓度比例与HLJDT中的不同,对此应深入研究以阐明HLJDT的药理作用和作用机制。